ML-193

Item number	Size	Delivery time	Price
TGM-T22103-5mg	5 mg	7 - 10 business days*	38.00€
TGM-T22103-1mL	1 ml	7 - 10 business days*	54.00€
TGM-T22103-10mg	10 mg	7 - 10 business days*	64.00€
TGM-T22103-25mg	25 mg	7 - 10 business days*	105.00€
TGM-T22103-50mg	50 mg	7 - 10 business days*	159.00€
TGM-T22103-100mg	100 mg	7 - 10 business days*	-

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: ML-193 (CID 1261822) is a potent and selective GPR55 antagonist (IC50: 221 nM) with... more

Close menu

Product information "ML-193"

Description: ML-193 (CID 1261822) is a potent and selective GPR55 antagonist (IC50: 221 nM) with over 27-fold selectivity for GPR55 over GPR35, CB1, and CB2. It can ameliorate motor and sensorimotor deficits in Parkinson's disease (PD) rats. Target: Cannabinoid Receptor. Smiles: Cc1noc(NS(=O)(=O)c2ccc(NC(=O)c3cc(nc4c(C)cc(C)cc34)-c3ccccn3)cc2)c1C. References: Fatemi I, et, al. The effect of intra-striatal administration of GPR55 agonist (LPI) and antagonist (ML193) on sensorimotor and motor functions in a Parkinson's disease rat model. Acta Neuropsychiatr. 2021 Feb,33(1):15-21.

Keywords:	CID 1261822
Supplier:	TargetMol
Supplier-Nr:	T22103

Properties

MW:	527.59 D
Formula:	C28H25N5O4S

Database Information

CAS :

713121-80-3| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+20°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "ML-193"

Write a review